- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06332833
Availability of Venous Conduits in Patients With Varicose Veins for Arterial Bypass Surgery
March 22, 2024 updated by: Pirogov Russian National Research Medical University
Patients with PAD having superficial femoral artery (SFA) occlusion were consecutively enrolled.
Demographic data and medical history were taken.
Physical examination and duplex ultrasound were performed.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Patients with PAD having superficial femoral artery (SFA) occlusion were consecutively enrolled.
Demographic data and medical history were taken.
Physical examination and duplex ultrasound were performed.
The investigators registered presence of varicose veins, type of previous invasive procedure and availability of saphenous trunks as possible grafts
Study Type
Observational
Enrollment (Estimated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pirogov Russian National Research Medical University
-
Moscow, Pirogov Russian National Research Medical University, Russian Federation, 109044
- Recruiting
- Veronika Golovina
-
Contact:
- Veronika Golovina, MD, PHD
- Phone Number: +79776051708
- Email: nikuskin@inbox.ru
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients with PAD having superficial femoral artery (SFA) occlusion.
Description
Inclusion Criteria:
- Older than 18 Years
Exclusion Criteria:
- Those unwilling to sign an informed consent were also included.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
availability of saphenous trunks as possible grafts
Time Frame: at the moment of inclusion
|
availability of saphenous trunks as possible grafts (Yes|No)
|
at the moment of inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
presence of varicose veins
Time Frame: at the moment of inclusion
|
presence of varicose veins (Yes|No)
|
at the moment of inclusion
|
type of previous invasive procedure
Time Frame: at the moment of inclusion
|
Phlebectomy\ radiofrequency ablation\ endovenous laser ablation (Yes|No)
|
at the moment of inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2023
Primary Completion (Estimated)
May 31, 2024
Study Completion (Estimated)
May 31, 2024
Study Registration Dates
First Submitted
March 15, 2024
First Submitted That Met QC Criteria
March 22, 2024
First Posted (Actual)
March 27, 2024
Study Record Updates
Last Update Posted (Actual)
March 27, 2024
Last Update Submitted That Met QC Criteria
March 22, 2024
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 235
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaNot yet recruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Marissa JarosinskiRecruitingPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
-
Jena University HospitalAngioDroid s.r.l., Bologna (Italy)CompletedPeripheral Arterial Occlusive DiseaseGermany
-
Seoul National University HospitalAstellas Pharma Korea, Inc.CompletedPeripheral Arterial Occlusive DiseaseKorea, Republic of
-
Heidelberg UniversityTerminatedPeripheral Arterial Occlusive DiseaseGermany
-
Johann Wolfgang Goethe University HospitalSuspendedPeripheral Arterial Occlusive DiseaseGermany